Skip to the page

Data / Drug companies / MSN Life Sciences Private Limited

MSN Life Sciences Private Limited: 48 products in the FDA NDC directory, labeler code 72640

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

MSN Life Sciences Private Limited (labeler code 72640) lists 48 products in the FDA National Drug Code Directory. By type: 48 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 9, 2026.

The request: Watch MSN Life Sciences Private Limited (FDA labeler code 72640): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72640
Products in commercial distribution
48
Packages
48
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule V 2
Started marketing in the last 12 months
9
Earliest marketing start
October 31, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients48100%

Products by type

TypeProductsShare
Bulk ingredients48100%

Dosage forms

Dosage formProductsShare
Powder48100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Acoramidis hydrochloride72640-047PowderBulk ingredientsOctober 9, 2026
Benzgalantamine gluconate72640-049PowderBulk ingredientsMarch 30, 2026
Tegoprazan72640-048PowderBulk ingredientsMarch 30, 2026
Ensifentrine72640-044PowderBulk ingredientsMarch 27, 2026
Zavegepant hydrochloride72640-045PowderBulk ingredientsMarch 26, 2026
Fezolinetant72640-042PowderBulk ingredientsMarch 21, 2026
Calteridol calcium72640-046PowderBulk ingredientsMarch 13, 2026
Gadoteridol72640-043PowderBulk ingredientsJanuary 27, 2026
Levodopa72640-041PowderBulk ingredientsJanuary 5, 2026
Lisinopril72640-040PowderBulk ingredientsMarch 29, 2025
Maribavir72640-039PowderBulk ingredientsMarch 29, 2025
Sparsentan72640-038PowderBulk ingredientsMarch 29, 2025
Carbidopa72640-036PowderBulk ingredientsMarch 25, 2025
Cannabidiol72640-037PowderBulk ingredientsMarch 21, 2025
Atogepant72640-033PowderBulk ingredientsFebruary 1, 2025
Finerenone72640-032PowderBulk ingredientsJanuary 10, 2025
Samidorphan-l- malate72640-034PowderBulk ingredientsDecember 31, 2024
Vonoprazan fumarate72640-035PowderBulk ingredientsSeptember 30, 2024
Vericiguat72640-030PowderBulk ingredientsSeptember 28, 2024
Chlorthalidone72640-031PowderBulk ingredientsSeptember 25, 2024
Sitagliptin phosphate72640-028PowderBulk ingredientsMarch 28, 2024
Mesalamine72640-029PowderBulk ingredientsMarch 27, 2024
Voxelotor72640-027PowderBulk ingredientsSeptember 30, 2023
Opicapone72640-025PowderBulk ingredientsSeptember 30, 2023
Sucralfate72640-024PowderBulk ingredientsSeptember 30, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.